May 20, 2013 - ASM Signs Onto Letter Regarding NSF's Merit Review Process
The ASM joined over 100 organizations and institutions in a May 20 letter expressing concerns “about recent Congressional actions that call into question the National Science Foundation’s (NSF) merit review process for awarding research grants.” Organized by the Coalition for National Science Funding (CNSF), the letter notes that NSF’s merit review process “has a proven track record in supporting outstanding, fundamental research across all disciplines of science and engineering.”
May 12, 2012 - ASM Signs onto Letter Regarding NIH Salary Caps
The ASM joined 160 other organizations in signing a letter urging Congress to restore the salary limit imposed on extramural NIH researchers to Level I of the Executive Pay Scale.
February 24, 2012 - ASM Comments on NIH RFI on Diversity in the Biomedical Research Workforce
The ASM sent comments to the National Institutes of Health Advisory Committee to the NIH Director Working Group on Diversity in the Biomedical Research Workforce on the RFI NOT-OD-12-031.
The ASM sent letters to members of the House of Representatives commenting on the Grant Reform and New Transparency (GRANT) Act (H.R. 3433)
October 5, 2011 - ASM Comments on NIH RFI on Biomedical Research Training
The ASM submitted comments to the National Institutes of Health on the RFI NOT-OD-11-106: Input into the Deliberations of the Advisory Committee to the NIH Director Working Group on the Future Biomedical Research Workforce.
May 23, 2011 - John P. Holdren, Assistant to the President for Science and Technology and Director, Office of Science and Technology Policy Addressed the ASM Membership During asm2011 in New Orleans
Dr. Holdren presented the remarks, "Science and Technology Policy Challenges and Opportunities in the Obama Administration...and the role of Microbiology" during the President's Forum at the ASM General Meeting, asm2011 in New Orleans, LA.
Research Involving Recombinant DNA Molecules
September 17, 2012 - Revision of the NIH Guidelines to Include Synthetic Nucleic Acids and Clarification of Criteria for Section III-A-1-a Experiments
Update on the Revision of the NIH Guidelines to Include Synthetic Nucleic Acids and Clarification of Criteria for Section III-A-1-a Experiments
September 5, 2012 - Revision of the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines) to Include Synthetic Nucleic Acids and to Clarify Criteria for Section III-A-1-a Experiments
April 9, 2009 - ASM Comments on Revisions to the NIH Guidelines for Research Involving Recombinant DNA Molecules
The American Society for Microbiology submitted comments on the proposed revisions to the NIH Guidelines for Research Involving Recombinant DNA Molecules, published in the March 4, 2009 Federal Register.
June 6, 2007 - ASM Comments on Research Involving Recombinant DNA Molecules
The ASM sent comments to the National Institutes of Health Office of Biotechnology Activities about the Federal Register Notice, "Recombinant DNA Research: Proposed Actions Under the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines).
Open Access to Research Data
April 13, 2012 - OSTP Report on Public Access to Scientific Research Results
On April 13, the Office of Science and Technology (OSTP) released a report to Congress on issues related to improving the management and access to the results of federally funded scientific research. The report was required by the America Competes Reauthorization Act of 2010 (ACRA). The report says that the Task Force on Public Access to Scholarly Publications and a working group under the National Science and Technology Council (NSTC) have been evaluating objectives related to increasing public access to federally funded scientific research and that analysis of responses to requests for input show strong support for increasing access to scholarly publications describing research results. The NSTC groups are continuing to consider public comments and how they should be implemented.